These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1088 related items for PubMed ID: 15265161

  • 1. Allograft diabetic nephropathy may progress to end-stage renal disease.
    Salifu MO, Nicastri AD, Markell MS, Ghali H, Sommer BG, Friedman EA.
    Pediatr Transplant; 2004 Aug; 8(4):351-6. PubMed ID: 15265161
    [Abstract] [Full Text] [Related]

  • 2. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z, Ji SM, Chen DR, Wen JQ, Chen JS, Liu ZH, Li LS.
    Ren Fail; 2008 Aug; 30(6):611-6. PubMed ID: 18661411
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of de novo allograft diabetic nephropathy in renal allograft recipients.
    Prasad N, Gupta P, Jain M, Bhadauria D, Gupta A, Sharma RK, Kaul A.
    Exp Clin Transplant; 2013 Jun; 11(3):215-21. PubMed ID: 23767942
    [Abstract] [Full Text] [Related]

  • 4. Structural involvement in type 1 and type 2 diabetic nephropathy.
    Dalla Vestra M, Saller A, Bortoloso E, Mauer M, Fioretto P.
    Diabetes Metab; 2000 Jul; 26 Suppl 4():8-14. PubMed ID: 10922968
    [Abstract] [Full Text] [Related]

  • 5. Diabetes as the cause of end-stage renal disease affects the pattern of post kidney transplant rehospitalizations.
    Ramezani M, Ghoddousi K, Hashemi M, Khoddami-Vishte HR, Fatemi-Zadeh S, Saadat SH, Khedmat H, Naderi M.
    Transplant Proc; 2007 May; 39(4):966-9. PubMed ID: 17524864
    [Abstract] [Full Text] [Related]

  • 6. Renal transplantation in patients with diabetes mellitus--revisited.
    Zincke H, Woods JE, Sterioff S, Johnson WJ, Palumbo PJ, Mitchell JC, Frohnert PP, Anderson CF, Service FJ, Leary FJ.
    Transplant Proc; 1979 Mar; 11(1):55-9. PubMed ID: 377694
    [Abstract] [Full Text] [Related]

  • 7. [Incidence and clinical characteristics of renal insufficiency in diabetic patients].
    Schwenger V, Müssig C, Hergesell O, Zeier M, Ritz E.
    Dtsch Med Wochenschr; 2001 Nov 23; 126(47):1322-6. PubMed ID: 11719856
    [Abstract] [Full Text] [Related]

  • 8. The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation.
    Ji S, Liu M, Chen J, Yin L, Sha G, Chen H, Liu Z, Li L.
    Clin Transplant; 2004 Oct 23; 18(5):536-40. PubMed ID: 15344956
    [Abstract] [Full Text] [Related]

  • 9. A case of living-related renal transplant from the donor with membranous nephropathy.
    Akioka K, Okamoto M, Ushigome H, Nobori S, Suzuki T, Sakai K, Sakamoto S, Urasaki K, Yanagisawa A, Fukatsu A, Yoshimura N.
    Clin Transplant; 2009 Aug 23; 23 Suppl 20():62-6. PubMed ID: 19594600
    [Abstract] [Full Text] [Related]

  • 10. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS, Al-Suwaida A, Isnani AC, Al-Harbi A, Alam A.
    Saudi J Kidney Dis Transpl; 2009 May 23; 20(3):402-9. PubMed ID: 19414942
    [Abstract] [Full Text] [Related]

  • 11. Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy.
    Jeong HJ, Park SK, Cho YM, Kim MS, Kim YS, Choi J, Kim SI, Lim BJ.
    Hum Pathol; 2008 Oct 23; 39(10):1511-8. PubMed ID: 18620732
    [Abstract] [Full Text] [Related]

  • 12. Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria.
    Okada T, Nagao T, Matsumoto H, Nagaoka Y, Wada T, Nakao T.
    Nephrology (Carlton); 2012 Jan 23; 17(1):68-75. PubMed ID: 21933307
    [Abstract] [Full Text] [Related]

  • 13. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM, Mauer M, International Diabetic Nephropathy Study Group.
    Pediatr Endocrinol Rev; 2008 Aug 23; 5 Suppl 4():958-63. PubMed ID: 18806710
    [Abstract] [Full Text] [Related]

  • 14. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov 23; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

  • 15. Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases.
    Masutani K, Katafuchi R, Ikeda H, Yamamoto H, Motoyama K, Sugitani A, Kanai H, Kumagai H, Hirakata H, Tanaka M, Iida M.
    Clin Transplant; 2005 Nov 23; 19 Suppl 14():59-64. PubMed ID: 15955171
    [Abstract] [Full Text] [Related]

  • 16. Complete remission of diabetic nephropathy in a type 1 diabetic patient with near-nephrotic range proteinuria and reduced renal function.
    Haraguchi K, Hara S, Ubara Y, Tanaka S, Nukui I, Shimura H, Ohashi K, Kobayashi T.
    Diabetes Res Clin Pract; 2009 Mar 23; 83(3):295-9. PubMed ID: 19162360
    [Abstract] [Full Text] [Related]

  • 17. Proteinuria after conversion to sirolimus in renal transplant recipients.
    Sahin GM, Sahin S, Kantarci G, Ergin H.
    Transplant Proc; 2006 Dec 23; 38(10):3473-5. PubMed ID: 17175308
    [Abstract] [Full Text] [Related]

  • 18. Development of a lesion resembling diabetic nephropathy in a renal homograft.
    Doud R, Lee DB, Waisman J, Bergstein JM.
    Arch Intern Med; 1977 Jul 23; 137(7):945-7. PubMed ID: 327961
    [Abstract] [Full Text] [Related]

  • 19. Non-diabetic renal disease in patients with type 2 diabetes mellitus.
    Prakash J, Sen D, Usha, Kumar NS.
    J Assoc Physicians India; 2001 Apr 23; 49():415-20. PubMed ID: 11762610
    [Abstract] [Full Text] [Related]

  • 20. A primer on recurrent and de novo glomerulonephritis in renal allografts.
    Ivanyi B.
    Nat Clin Pract Nephrol; 2008 Aug 23; 4(8):446-57. PubMed ID: 18560395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.